Accordingly, a high percent of CD4+ T cells in the tumor microenvironment may predict poor prognosis in NSCLC [36], and cytotoxic Th1 cells and dendritic cells can maintain anti-tumor immunity [36]. This evidence concerns the gene CD4 and neoplasm.